EFFECTS OF ENDOTHELIN-1 AND CONVERSION OF BIG ENDOTHELIN-1 IN THE ISOLATED PERFUSED RABBIT LUNG

被引:19
作者
ISHIKAWA, S
TSUKADA, H
YUASA, H
FUKUE, M
WEI, S
ONIZUKA, M
MIYAUCHI, T
ISHIKAWA, T
MITSUI, K
GOTO, K
HORI, M
机构
[1] UNIV TSUKUBA,INST CLIN MED,DEPT SURG,TSUKUBA,IBARAKI 305,JAPAN
[2] UNIV TSUKUBA,INST BASIC SCI,TSUKUBA,IBARAKI 305,JAPAN
[3] UNIV TSUKUBA,INST CLIN MED,DEPT PHARMACOL,TSUKUBA,IBARAKI 305,JAPAN
关键词
PULMONARY HYPERTENSION; PROSTAGLANDINS; ENDOTHELIAL PERMEABILITY; ENDOTHELIN-CONVERTING ENZYME; PHOSPHORAMIDON;
D O I
10.1152/jappl.1992.72.6.2387
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
We examined the effects of endothelin-1 (ET-1) on pulmonary hemodynamic and transvascular fluid filtration and the conversion of big endothelin-1 (big ET-1), a precursor of ET-1, in isolated perfused rabbit lungs at constant vascular and airway pressures. Furthermore we examined whether ET-1 contributes to cyclooxygenase metabolism. The perfusate flow decreased significantly after bolus administration of 1 or 0.1 nmol of ET-1. Lung weight did not increase throughout the experimental period. Big ET-1- (1 nmol) induced decrease in the flow was slow in developing, although the maximum response was comparable to that induced by the same dose of ET-1. The concentration of big ET-1 in the perfusate progressively decreased, while that of ET-1 increased in a time-dependent manner. Phosphoramidon, an inhibitor of metalloproteinase, suppressed the pressor effect of big ET-1 (P < 0.01) and the increase in the concentration of ET-1 in the perfusate (P < 0.05). The present findings provide the first evidence suggesting that the potent vasocontractile effect of big ET-1 in pulmonary circulation can be attributed to the production of ET-1 by the conversion from big ET-1 in the vascular bed. ET-1-induced perfusate flow changes were not affected by indomethacin, and the concentration of 6-ketoprostaglandin F1-alpha, a metabolite of prostacyclin, did not increase after ET-1 administration.
引用
收藏
页码:2387 / 2392
页数:6
相关论文
共 27 条
[1]  
BAKHLE YS, 1980, EUR J PHARMACOL, V68, P479
[2]   SUSTAINED EFFECTS OF ENDOTHELIN-1 ON RABBIT, DOG, AND RAT PULMONARY CIRCULATIONS [J].
BARNARD, JW ;
BARMAN, SA ;
ADKINS, WK ;
LONGENECKER, GL ;
TAYLOR, AE .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (02) :H479-H486
[3]  
BHATTACHARYA J, 1980, J APPL PHYSIOL, V48, P444, DOI 10.1152/jappl.1980.48.3.444
[4]  
DENUCCI G, 1988, P NATL ACAD SCI USA, V85, P9797
[5]   ANALYSIS OF RESPONSES TO ENDOTHELINS 1, 2, AND 3 AND SARAFOTOXIN 6B IN AIRWAYS OF THE CAT [J].
DYSON, MC ;
KADOWITZ, PJ .
JOURNAL OF APPLIED PHYSIOLOGY, 1991, 71 (01) :243-251
[6]   ENDOTHELIN-1 CAUSES PULMONARY VASODILATION IN RATS [J].
HASUNUMA, K ;
RODMAN, DM ;
OBRIEN, RF ;
MCMURTRY, IF .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (01) :H48-H54
[7]   VASCULAR REACTIVITY AND PERMEABILITY TO SEROTONIN IN CYCLOOXYGENASE-INHIBITED DOG LUNG [J].
HOFMAN, WF ;
EHRHART, IC .
AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 255 (05) :H1096-H1105
[8]   NISOLDIPINE INHIBITS VASOCONSTRICTOR RESPONSES IN THE CAT PULMONARY VASCULAR BED [J].
KADOWITZ, PJ ;
LIPPTON, HL ;
BELLAN, JA ;
HYMAN, AL .
JOURNAL OF APPLIED PHYSIOLOGY, 1989, 66 (06) :2885-2890
[9]   PUTATIVE PRECURSORS OF ENDOTHELIN HAVE LESS VASOCONSTRICTOR ACTIVITY INVITRO BUT A POTENT PRESSOR EFFECT INVIVO [J].
KASHIWABARA, T ;
INAGAKI, Y ;
OHTA, H ;
IWAMATSU, A ;
NOMIZU, M ;
MORITA, A ;
NISHIKORI, K .
FEBS LETTERS, 1989, 247 (01) :73-76
[10]   CONVERSION OF BIG ENDOTHELIN-1 TO 21-RESIDUE ENDOTHELIN-1 IS ESSENTIAL FOR EXPRESSION OF FULL VASOCONSTRICTOR ACTIVITY - STRUCTURE ACTIVITY RELATIONSHIPS OF BIG ENDOTHELIN-1 [J].
KIMURA, S ;
KASUYA, Y ;
SAWAMURA, T ;
SHINMI, O ;
SUGITA, Y ;
YANAGISAWA, M ;
GOTO, K ;
MASAKI, T .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 13 :S5-S7